What is the ticker symbol for NovaBridge Biosciences?

NovaBridge Biosciences trades under the ticker NBP on NASDAQ.

What sector does NovaBridge Biosciences operate in?

NovaBridge Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NBP in a portfolio?

PortView shows NBP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

NovaBridge Biosciences (NBP) Stock Analysis

NASDAQHealthcareBiotechnology

$1.77+2.17%

1-year price historyRange $1.47 – $6.56

52-week range$1.77

$1.46$6.79

What NovaBridge Biosciences does

NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several significant drug candidates: givastomig, a bispecific antibody currently in Phase 1b clinical trials for gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, another bispecific antibody, which is undergoing Phase 1 clinical evaluation for solid tumors. The company maintains a strategic licensing agreement with Ferring International Center SA, encompassing the research, development, manufacturing, import, use, and commercialization rights for FE301, an interleukin-6 inhibitor. Additionally, NovaBridge Biosciences has established collaborations with Bristol Myers Squibb for givastomig's advancement, ABL Bio, Inc. for both givastomig and ragistomig, and TJ Bio for uliledlimab. Founded in 2014 and headquartered in Rockville, Maryland, the entity was formerly named I-Mab, with its transition to NovaBridge Biosciences slated for October 2025.

Key metrics

Market cap

$203.74M

P/E (TTM)

-4.53

EPS (TTM)

$-0.39

Beta

1.48

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.82

200-day avg

$2.73

52-week high

$6.79

52-week low

$1.46

CEO

Srishti Gupta

ETFs linked to NBP

Broad-market and Healthcare sector ETFs an investor holding NovaBridge Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NBP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NBP in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for NovaBridge Biosciences?: NovaBridge Biosciences trades under the ticker NBP on NASDAQ.
Which exchange is NBP listed on?: NBP is listed on NASDAQ.
What sector does NovaBridge Biosciences operate in?: NovaBridge Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NBP in a portfolio?: PortView shows NBP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.